You finally cleared your acne. And now you're looking at a constellation of dark spots, pink marks, and little dips in your skin that seem like they might be there forever. You've tried vitamin C. You've tried niacinamide. Some of the marks have faded; others haven't moved at all. There's a reason for that.
"Acne scars" is a term that covers at least four distinct things. They respond differently to treatment because they're different problems. Knowing which type you're dealing with is the actual first step.
What type of scar do you have?
Post-inflammatory hyperpigmentation (PIH) is the flat, dark discoloration left after an inflamed spot heals. It's not a scar in the structural sense — it's excess melanin deposited during inflammation. It fades over time without treatment, but the right actives accelerate that significantly. PIH tends to be more pronounced and longer-lasting in medium to dark skin tones.
Post-inflammatory erythema (PIE) is the pink or red mark left after acne in lighter skin tones. This is vascular, not pigment-based — it's caused by dilated capillaries and residual inflammation. Brightening serums and AHAs don't address vascular change, which is why PIE doesn't respond to the same products as PIH. It fades on its own over months, or responds better to vascular-targeting treatments like azelaic acid or, at the clinical level, pulsed dye laser.
Atrophic scars are the textured changes — the ice-pick, boxcar, and rolling scars that alter the skin's surface. These represent actual collagen and tissue loss in the dermis. They don't respond to topical treatments in any meaningful way. They require procedures to address.
A 2023 systematic review in the Journal of Cosmetic Dermatology assessed the evidence hierarchy for atrophic acne scar treatment. Microneedling with radiofrequency was ranked among the most effective options for rolling and boxcar scars, with a lower side-effect profile than ablative laser resurfacing. Subscision (physically breaking the fibrous bands that pull rolling scars inward) showed strong evidence as an add-on to other procedures. For ice-pick scars, punch techniques and TCA cross chemical reconstruction showed the most consistent results. The review confirmed that no single treatment works for all scar types — combination protocols matched to scar morphology consistently outperform single-modality approaches.
What actually works for PIH (dark spots)
Tretinoin is the most evidence-backed OTC-accessible (prescription in the US) option for PIH. It accelerates cell turnover, moves pigmented cells out of the epidermis faster, and has multiple controlled trials showing measurable improvement in 12 weeks. Consistent daily use with strict SPF is required; unprotected UV exposure reverses progress.
Vitamin C (L-ascorbic acid) inhibits tyrosinase, reducing new melanin production. It works better as a preventive than a corrective and is most effective when combined with SPF. Niacinamide reduces the transfer of melanin to skin cells — useful for maintenance but slower-acting than tretinoin. Azelaic acid works for both PIH and PIE and is particularly well-suited to sensitive skin types.
Any active targeting PIH will be partially reversed by UV exposure that isn't blocked. SPF isn't optional when treating pigmentation — it's half the treatment. Mineral SPF (zinc oxide) is the most reliable choice for skin that's prone to hyperpigmentation and is actively being treated with actives. Use it every morning, regardless of whether you're going outside.
When to see a dermatologist
For PIH, a dermatologist can prescribe compounded treatments (tretinoin combined with hydroquinone and a mild corticosteroid) that are more effective than any OTC option for deeper pigmentation — and can tailor the approach to your skin tone to reduce risk of irritation-triggered PIH.
For atrophic scars, professional assessment is the actual starting point. The right combination of microneedling, chemical peels, subscision, or laser depends on the depth and type of scarring, your skin tone, and your budget. Getting a realistic picture of what's achievable — and in how many sessions — is more useful than buying expensive serums that won't address textural scars.
Tretinoin (prescription), vitamin C (L-ascorbic acid 10–20%), niacinamide (5–10%), azelaic acid (10–20%). All with consistent SPF. Tretinoin has the strongest evidence. Don't layer all of these at once — start with one, add slowly.
Azelaic acid is the best-evidenced topical option. Time is also a factor — PIE in lighter skin tones typically fades over 6–12 months without treatment. Avoid harsh exfoliation, which can worsen vascular response.
Microneedling, microneedling with RF, chemical peels (TCA), subscision, punch techniques, and ablative/fractional laser — chosen based on scar type. Expect multiple sessions and months of results. This is not a one-appointment fix.
What to tell your dermatologist
- "I have a mix of dark spots and textured scars — can we address them in separate protocols?" — they often need different approaches
- "What's the best option for PIH in my skin tone specifically?" — treatment approach differs significantly across Fitzpatrick scale skin tones
- "I'm interested in microneedling — am I a good candidate, and how many sessions would be realistic?" — get a real timeline, not marketing language
- "Is there a prescription topical combination that would be more effective than what I'm using?" — especially relevant for stubborn deep PIH
A note from our medical advisors
The most important thing to know about atrophic scars: don't start treating them until the active acne is controlled. Microneedling over active breakouts makes things worse. The sequence matters: get the acne managed first, then address the scars. This is where having a dermatologist involved makes a real difference — they can manage both in sequence rather than you trying to do both at once and canceling out your results.
References
- Fife D, et al. Dermatologists and aestheticians' evaluation of acne scar types and their treatment preferences. J Drugs Dermatol. 2011;10(4):426–432. PubMed 21442150
- Hession MT, Graber EM. Atrophic acne scarring: a review of treatment options. J Clin Aesthet Dermatol. 2015;8(1):50–58. PubMed 25741399
- Ramos-e-Silva M, et al. Post-inflammatory hyperpigmentation: a review. Cutis. 2007;79(5):S19–26. PubMed 17674586
- Dogra S, Yadav S. Acne in skin of color: special considerations. J Eur Acad Dermatol Venereol. 2011;25(2):143–151. PubMed 20560970